-
公开(公告)号:US20110213131A1
公开(公告)日:2011-09-01
申请号:US13063548
申请日:2009-09-11
申请人: Caspar Christensen , Rune Severinsen , Anders Klarskov Petersen , Steffen Kidal , Claus U. Jessen , Peter Madsen , Henrik Valore , Tina Møller Tagmose , Jan Lindy Sørensen
发明人: Caspar Christensen , Rune Severinsen , Anders Klarskov Petersen , Steffen Kidal , Claus U. Jessen , Peter Madsen , Henrik Valore , Tina Møller Tagmose , Jan Lindy Sørensen
CPC分类号: C07K1/1077 , A61K47/54 , C07K14/605 , C07K14/62
摘要: A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
摘要翻译: 描述了选择性酰化具有两个或更多个反应性亲核官能团的肽或蛋白质中的氨基的方法。
-
公开(公告)号:US08637647B2
公开(公告)日:2014-01-28
申请号:US13063548
申请日:2009-09-11
申请人: Caspar Christensen , Rune Severinsen , Anders Klarskov Petersen , Steffen Kidal , Claus U. Jessen , Peter Madsen , Henrik Valore , Tina Møller Tagmose , Jan Lindy Sørensen
发明人: Caspar Christensen , Rune Severinsen , Anders Klarskov Petersen , Steffen Kidal , Claus U. Jessen , Peter Madsen , Henrik Valore , Tina Møller Tagmose , Jan Lindy Sørensen
CPC分类号: C07K1/1077 , A61K47/54 , C07K14/605 , C07K14/62
摘要: A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
-
公开(公告)号:US07208497B2
公开(公告)日:2007-04-24
申请号:US10185861
申请日:2002-06-27
IPC分类号: A61K31/495 , A61K31/496 , C07D295/185 , C07D405/06 , C07D401/04 , C07D405/04 , C07D405/14
CPC分类号: C07D213/74 , C07D213/54 , C07D213/56 , C07D231/12 , C07D243/08 , C07D263/58 , C07D277/74 , C07D295/185 , C07D295/192 , C07D295/205 , C07D307/81 , C07D309/14 , C07D317/30 , C07D317/60 , C07D317/62 , C07D319/18 , C07D333/60 , C07D405/12 , C07D409/12 , C07D413/12
摘要: A novel class of substituted piperazines and diazepanes, pharmaceutical compositions comprising them and use thereof in the treatment of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
摘要翻译: 一类新的取代的哌嗪和二氮杂环庚烷,包含它们的药物组合物及其用于治疗与组胺H3受体相关的疾病和病症的用途。 更具体地说,这些化合物可用于治疗与组胺H3受体相互作用有益的疾病和病症。
-
-